(Mesenchymal) Stem Cell-Based Therapy in Cisplatin-Induced Acute Kidney Injury Animal Model: Risk of Immunogenicity and Tumorigenicity
Pathogenesis of AKI is complex and involves both local events in the kidney as well as systemic effects in the body that are interconnected and interdependent. Despite intensive investigations there is still no pharmacological agent that could provide complete protection against cisplatin nephrotoxi...
Saved in:
Main Authors: | Ž. Večerić-Haler, A. Cerar, M. Perše |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2017-01-01
|
Series: | Stem Cells International |
Online Access: | http://dx.doi.org/10.1155/2017/7304643 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Efficacy of Mesenchymal Stem Cells in Therapy of Acute Kidney Injury Induced by Ischemia-Reperfusion in Animal Models
by: Tianbiao Zhou, et al.
Published: (2020-01-01) -
Mechanism of dexmedetomidine protection against cisplatin induced acute kidney injury in rats
by: Zeng-lu Zheng, et al.
Published: (2024-12-01) -
The Regulation of Inflammatory Mediators in Acute Kidney
Injury via Exogenous Mesenchymal Stem Cells
by: Tao Du, et al.
Published: (2014-01-01) -
Secretomes from Mesenchymal Stem Cells against Acute Kidney Injury: Possible Heterogeneity
by: Kenji Tsuji, et al.
Published: (2018-01-01) -
Cell Transplantation for Spinal Cord Injury: Tumorigenicity of Induced Pluripotent Stem Cell-Derived Neural Stem/Progenitor Cells
by: Junhao Deng, et al.
Published: (2018-01-01)